1
|
Cañedo-Solares I, Correa D, Luna-Pastén H, Ortiz-Alegría LB, Gómez-Chávez F, Xicoténcatl-García L, García LD, Canfield-Rivera CE. Maternal anti-Toxoplasma gondii antibodies IgG2, IgG3 and IgG1 are markers of vertical transmission and clinical evolution of toxoplasmosis in the offspring. Acta Trop 2023; 243:106943. [PMID: 37172708 DOI: 10.1016/j.actatropica.2023.106943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 05/06/2023] [Accepted: 05/09/2023] [Indexed: 05/15/2023]
Abstract
Toxoplasma gondii can be transmitted vertically during pregnancy and may cause neurological, ocular, and even systemic damage to the offspring. Congenital toxoplasmosis (CT) can be diagnosed during gestation and/or after birth in the postnatal period. The timely diagnosis is highly relevant for efficient clinical management. The most common laboratory methods for diagnosing CT are based on Toxoplasma-specific humoral immune responses. However, these methods are of low sensitivity or specificity. In a previous study with a small number of cases, the comparison of anti-T. gondii IgG subclasses between mothers and their offspring showed promising results for CT diagnosis and prognosis. Thus, in this work, we analyzed specific IgG subclasses and IgA in 40 T. gondii-infected mothers and their children, of which 27 were congenitally infected and 13 uninfected. A higher frequency of anti-Toxoplasma IgG2, IgG3, IgG4, and IgA antibodies was observed in mothers and congenitally infected offspring. Of these, IgG2 or IgG3 were statistically the most conspicuous. In the CT group, maternal IgG3 antibodies were significantly associated with severe disease of the infants and IgG1 and IgG3 with disseminated disease. The results support that maternal anti-T. gondii IgG3, IgG2 and IgG1 are markers of congenital transmission and severity/spread of disease in the offspring.
Collapse
Affiliation(s)
- Irma Cañedo-Solares
- Laboratorio de Inmunología Experimental, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, México.
| | - Dolores Correa
- Dirección de Investigación / Centro de Investigación en Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Anáhuac, México.
| | - Hector Luna-Pastén
- Laboratorio de Inmunología Experimental, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, México
| | - Luz Belinda Ortiz-Alegría
- Laboratorio de Inmunología Experimental, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, México
| | - Fernando Gómez-Chávez
- Laboratorio de Inmunología Experimental, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, México; Laboratorio de Enfermedades Osteoarticulares e Inmunológicas, Sección de Estudios de Posgrado e Investigación, ENMyH - IPN, México
| | - Lizbeth Xicoténcatl-García
- Laboratorio de Inmunología Experimental, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, México
| | - Luisa Díaz- García
- Departamento de Metodología de la Investigación, Instituto Nacional de Pediatría, Secretaría de Salud, México
| | | |
Collapse
|
2
|
Bahreini MS, Sami Jahromi S, Radfar AH, Salemi AM, Dastan N, Asgari Q. The Relationship of Latent Toxoplasmosis and Cigarette Smoking: Seroprevalence, Risk Factor, and Case-Control Study in Fars Province, Southern Iran. Pathogens 2022; 11:1274. [PMID: 36365025 PMCID: PMC9696781 DOI: 10.3390/pathogens11111274] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 09/06/2022] [Accepted: 09/15/2022] [Indexed: 12/20/2023] Open
Abstract
Toxoplasmosis is a parasitic disease with worldwide prevalence. Despite the relatively similar effects of toxoplasmosis and smoking on alteration in neurotransmitters, especially dopamine, little is known about the relation of Toxoplasma gondii infection and addiction to cigarette smoking. Therefore, the main objective of this study was to assess the relationship between latent toxoplasmosis and smoking. Through a case-control study, 216 regular cigarette smokers and 324 nonsmoker age- and gender-matched subjects were evaluated for anti-T.gondii IgG antibodies with enzyme-linked immunosorbent assay (ELISA). During the sampling, a structured questionnaire was used to obtain the demographic information of participants and the risk factors of acquired Toxoplasma. The median ages of case and control groups were 51.04 ± 18.1 (22-97 years) and 51.03 ± 16.5 (21-89 years), respectively (p = 0.99). Anti-T.gondii IgG antibodies were detected in 44 (20.37%) cases and in 135 (41.67%) controls. There was a statistically significant difference for the positivity rate between the smokers and the control group (OR = 0.35; 95%CI: 0.19-0.65; and p = 0.001). The overall prevalence was 33.14%. This study indicated the inverse association between seropositivity to Toxoplasma infection and cigarette smoking. This relationship could be due to the changes that latent toxoplasmosis has on the neurotransmitters, especially dopamine, which needs more research.
Collapse
Affiliation(s)
- Mohammad Saleh Bahreini
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran
| | - Sareh Sami Jahromi
- Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran
| | - Amir Hossein Radfar
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran
| | - Amir Masoud Salemi
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran
| | - Naghmeh Dastan
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran
| | - Qasem Asgari
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran
| |
Collapse
|
3
|
Borges HDS, Oliveira-Scussel ACM, Oliveira ÂMM, Abdallah VOS, Pajuaba ACAM, Mineo JR. Comparative Detection of Immunoglobulin Isotypes and Subclasses against Toxoplasma gondii Soluble Antigen in Serum and Colostrum Samples from Puerperal Women. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19137953. [PMID: 35805611 PMCID: PMC9265988 DOI: 10.3390/ijerph19137953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/27/2022] [Revised: 06/17/2022] [Accepted: 06/19/2022] [Indexed: 11/17/2022]
Abstract
Background: Toxoplasma gondii is an obligate intracellular parasite that can infect several species, including humans, and can cause severe damage to the fetus when the infection occurs during pregnancy. The environment and/or food contamination are critical to spreading the infection. Human milk is rich in nutrients and bioactive elements that provide growth and development of the immune system of the newborn. All isotypes of immunoglobulins are present in human colostrum and they are produced from systemic or local sources. Breastfeeding protects the infant against various pathogens, but there is no conclusive study to detect IgG subclasses in colostrum against T. gondii. Therefore, the aim of this study was to detect and evaluate the presence of antibody isotypes against T. gondii in paired samples of serum and colostrum. Methods: The study included 283 puerperal patients. ELISA (Enzyme-Linked Immunosorbent Assay) for detection of anti-T. gondii-specific IgM, IgA, and IgG isotypes and IgG1, IgG3, and IgG4 subclasses were conducted on paired samples of serum and colostrum. Results: It was found that 45.9%, 6.0%, and 2.1% of serum samples and 45.2%, 7.1%, and 2.1% of colostrum samples were positive for IgG, IgM, and IgA, respectively. Specific IgG1, IgG3, and IgG4 were positive, respectively, in 98.5%, 54.6%, and 44.6% of serum samples, in contrast with 56.9%, 78.5%, and 34.6% of colostrum samples. Thus, the predominant reactivity of IgG subclasses against T. gondii was IgG1 in serum and IgG3 in colostrum. The higher percentage of positive samples and higher levels of anti-T. gondii IgG3 antibodies were observed in colostrum, when compared to serum samples, suggesting a local production of this subclass. IgG3 and IgG1 subclasses presented different percentages of positivity in serum and colostrum. Only the IgG1 subclass showed a significant correlation between the levels of anti-T. gondii in serum and colostrum, suggesting that IgG1 in breast milk comes from a systemic source. IgG4 showed a similar percentage of positivity in both sample types, but no significant correlation was observed between their levels. Conclusion: Colostrum presents representative levels of IgM, IgA, IgG1, IgG3, and IgG4 antibodies specific to T. gondii. The detection of these antibodies presents the potential for diagnostic application of colostrum samples to better identify the diagnostic status of T. gondii infection, especially during the acute phase. In addition, breastfeeding can also be a possible source of protective antibodies for the newborn against toxoplasmosis, an anthropozoonosis maintained by environmental infection, which interferes in the public health of many countries.
Collapse
Affiliation(s)
- Hellen Dayane Silva Borges
- Laboratory of Immunoparasitology “Dr. Mário Endsfeldz Camargo”, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia 38405-317, MG, Brazil; (H.D.S.B.); (A.C.M.O.-S.); (A.C.A.M.P.)
| | - Ana Carolina Morais Oliveira-Scussel
- Laboratory of Immunoparasitology “Dr. Mário Endsfeldz Camargo”, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia 38405-317, MG, Brazil; (H.D.S.B.); (A.C.M.O.-S.); (A.C.A.M.P.)
- Biomedicine Teaching Laboratory, Institute of Health Sciences, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil
| | - Ângela Maria Morais Oliveira
- Human Milk Bank, The Clinics Hospital of Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Uberlândia 38405-320, MG, Brazil;
| | - Vânia Olivetti Steffen Abdallah
- Department of Pediatrics, The Clinics Hospital, Faculty of Medicine, Universidade Federal de Uberlândia, Uberlândia 38405-320, MG, Brazil;
| | - Ana Cláudia Arantes Marquez Pajuaba
- Laboratory of Immunoparasitology “Dr. Mário Endsfeldz Camargo”, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia 38405-317, MG, Brazil; (H.D.S.B.); (A.C.M.O.-S.); (A.C.A.M.P.)
| | - José Roberto Mineo
- Laboratory of Immunoparasitology “Dr. Mário Endsfeldz Camargo”, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia 38405-317, MG, Brazil; (H.D.S.B.); (A.C.M.O.-S.); (A.C.A.M.P.)
- Correspondence:
| |
Collapse
|
4
|
Evaluation of Toxoplasma gondii recombinant antigens for early diagnosis of congenital toxoplasmosis. Diagn Microbiol Infect Dis 2021; 102:115608. [PMID: 34942587 DOI: 10.1016/j.diagmicrobio.2021.115608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 10/22/2021] [Accepted: 11/19/2021] [Indexed: 11/23/2022]
Abstract
The performance of Toxoplasma rGra8, rMic1, and the chimeric rGra4-Gra7 antigens for early congenital toxoplasmosis (CT) diagnosis was evaluated. Sera from CT patients showed high IgG reactivity to rMic1, rGra8, and rGra4-Gra7. The seroreactivity of samples from uninfected infants was lost within 2 months of age.
Collapse
|
5
|
Cañedo-Solares I, Gómez-Chávez F, Luna-Pastén H, Ortiz-Alegría LB, Flores-García Y, Figueroa-Damián R, Macedo-Romero CA, Correa D. What do anti-Toxoplasma gondiiIgA and IgG subclasses in human saliva indicate? Parasite Immunol 2018; 40:e12526. [DOI: 10.1111/pim.12526] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2017] [Accepted: 03/12/2018] [Indexed: 01/25/2023]
Affiliation(s)
- I. Cañedo-Solares
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
| | - F. Gómez-Chávez
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
- Cátedras CONACyT; Instituto Nacional de Pediatría; Ciudad de México México
| | - H. Luna-Pastén
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
| | - L. B. Ortiz-Alegría
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
| | - Y. Flores-García
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
| | - R. Figueroa-Damián
- Servicio de Infectología e Inmunología; Instituto Nacional de Perinatología, Secretaría de Salud; Ciudad de México México
| | - C. A. Macedo-Romero
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
| | - D. Correa
- Laboratorio de Inmunología Experimental; Subdirección de Medicina Experimental; Instituto Nacional de Pediatría, Secretaría de Salud; Ciudad de México México
| |
Collapse
|
6
|
de Castro Zacche-Tonini A, Fonseca GSF, de Jesus LNNP, Barros GB, Coelho-Dos-Reis JGA, Béla SR, Machado AS, Carneiro ACAV, Andrade GMQ, Vasconcelos-Santos DV, Januário JN, Teixeira-Carvalho A, Vitor RWA, Ferro EAV, Mineo JR, Martins-Filho OA, Lemos EM. Establishing tools for early diagnosis of congenital toxoplasmosis: Flow cytometric IgG avidity assay as a confirmatory test for neonatal screening. J Immunol Methods 2017; 451:37-47. [PMID: 28827190 DOI: 10.1016/j.jim.2017.08.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2017] [Revised: 08/17/2017] [Accepted: 08/17/2017] [Indexed: 11/24/2022]
Abstract
The aim of this study was to evaluate the performance of conventional serology (Q-Preven™ and ELFAVIDAS™) and flow cytometry-based serologic tools for early serologic diagnosis of congenital toxoplasmosis. The study groups included prospectively confirmed cases of congenital toxoplasmosis (TOXO=88) and age-matching non-infected controls (NI=15).The results demonstrated that all samples tested positive/indeterminate for anti-T. gondii IgM screening at birth using air-dried whole blood samples. Serum samples collected at 30-45days after birth tested positive for ELFAVIDAS™ IgG in both groups. While all NI tested negative for ELFAVIDAS™ IgM and IgA, only 78% and 36% of TOXO tested positive for IgM and IgA, respectively. Flow cytometry-based anti-T. gondii IgM, IgA and IgG reactivity displayed moderate performance with low sensitivity (47.6%, 72.6% and 75.0%, respectively). Regardless the remarkable specificity of IgG1, IgG2 and IgG3 subclasses for early diagnosis, weak or moderate specificity was observed (Se=73.9%, 60.2% and 83.0%, respectively). The analysis of IgG avidity indices (AI) demonstrated the highest performance among the flow cytometry-based methods (Se=96.6%; Sp=93.3%), underscoring the low avidity index (AI<60%) within TOXO (97.0%) in contrast with the high avidity index (AI>60%) in NI (93%). Analysis of anti-T. gondii IgG and IgG3 reactivity for mother:infant paired samples may represent a relevant complementary tests for early diagnosis. In conclusion, a feasible high-standard algorithm (Accuracy=97.1%) was proposed consisting of Q-Preven™ IgM screening at birth, followed by ELFAVIDAS™ IgM and flow cytometric IgG avidity analysis at 30-45days after birth as a high performance tool for early serological diagnosis of congenital toxoplasmosis.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Gláucia Manzan Queiroz Andrade
- Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil; Núcleo de Ações e pesquisa em Apoio Diagnóstico (NUPAD), Belo Horizonte, MG, Brazil
| | | | - José Nélio Januário
- Núcleo de Ações e pesquisa em Apoio Diagnóstico (NUPAD), Belo Horizonte, MG, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Meira CS, Vidal JE, Costa-Silva TA, Motoie G, Gava R, Hiramoto RM, Pereira-Chioccola VL. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients. J Immunol Methods 2013; 395:21-8. [PMID: 23811152 DOI: 10.1016/j.jim.2013.06.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2013] [Revised: 06/16/2013] [Accepted: 06/17/2013] [Indexed: 10/26/2022]
Abstract
Cerebral toxoplasmosis is the most common neurological opportunistic disease manifested in HIV infected patients. Excretory/secretory antigens (ESA) are serological markers for the diagnosis of reactivation of the infection in HIV-infected patients with cerebral toxoplasmosis. Immunosuppressed patients develop high antibody titers for ESA. However, little is known about the humoral response for these antigens. The present study analyzed the profile of antibody recognition against ESA in comparison with tachyzoite lysate antigen (TLA) in 265 sera and 270 cerebrospinal fluid (CSF) samples from infected patients with Toxoplasma gondii and or HIV and in sera of 50 healthy individuals. The samples of sera and CSF were organized in 8 groups. The sera sample groups were: Group I - Se/CT/AIDS (patients with cerebral toxoplasmosis/AIDS) with 58 samples; Group II - Se/ONinf/AIDS/PosT (patients with AIDS/other neuroinfections/positive toxoplasmosis) with 49 samples; Group III - Se/ONinf/AIDS/NegT (patients with AIDS/other neuroinfections/negative toxoplasmosis) with 58 samples; Group IV - Se/PosT/NegHIV (individuals with asymptomatic toxoplasmosis/negative HIV) with 50 samples and Group V - Se/NegT/NegHIV (healthy individuals/negative toxoplasmosis and HIV) with 50 samples. The CSF sample groups were: Group VI - CSF/CT/AIDS (patients with cerebral toxoplasmosis/AIDS) with 99 samples; Group VII - CSF/ONinf/AIDS/PosT (patients with AIDS/other neuroinfections/positive toxoplasmosis) with 112 samples, and Group VIII - CSF/ONinf/AIDS/NegT (patients with AIDS/other neuroinfections/negative toxoplasmosis) with 59 samples. Levels of IgM, IgA, IgE, IgG and subclasses were determined by ELISA against TLA and ESA antigens. IgM, IgA or IgE antibodies against ESA or TLA were not detected in sera from patients with toxoplasmosis suggesting that all patients were in chronic phase of the infection. High levels of IgG1 against TLA were found in sera samples from groups I, II and IV and in CSF samples from groups VI and VII; whereas IgG2, IgG3 and IgG4 levels were not detected in the same sera or CSF sample groups. However, patients from groups I and VI, that had tachyzoites circulating in blood and CSF respectively, produced a mix of IgG1 and IgG4 antibodies against ESA. IgG2 against ESA were predominant in serum from patients with the latent (non-active) T. gondii infection/HIV negative and in CSF samples from patients with other neuroinfections and positive toxoplasmosis (groups IV and VII, respectively). IgG4 levels against ESA were found to be significantly (P<0.05 and P<0.005) higher in patients with cerebral toxoplasmosis (groups I and VI, respectively) in comparison with groups II, IV and VII. This data suggest that IgG4 can be valuable for supporting the diagnosis of focal brain lesions, caused by T. gondii infection, in HIV-infected patients. This approach might be useful, mainly when molecular investigation to detect parasites is not available.
Collapse
Affiliation(s)
- Cristina S Meira
- Laboratorio de Parasitologia do Instituto Adolfo Lutz, Sao Paulo, SP, Brazil
| | | | | | | | | | | | | |
Collapse
|
8
|
Age-associated prevalence ofToxoplasma gondiiin 8281 pregnant women in Poland between 2004 and 2012. Epidemiol Infect 2013; 142:656-61. [DOI: 10.1017/s0950268813001179] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
SUMMARYThis study aimed to describeToxoplasma gondiiprevalence in Polish pregnant women and the incidence rates of congenital infections in their neonates observed between 2004 and 2012. Serological tests forT. gondii-specific IgG and IgM antibodies were performed on serum samples of 8281 pregnant women treated at the Polish Mother's Memorial Hospital Research Institute in Lodz. The yearly seroconversion rate forT. gondiiIgG antibodies was estimated using a mathematical model to determine the dependency between age and prevalence. Mean prevalence of IgG antibodies between 2004 and 2012 in pregnant women was 40·6% [95% confidence interval (CI) 39·6–41·7] and increased with age with a yearly seroconversion rate of 0·8% (95% CI 0·6–1·0,P < 0·001). Assuming aT. gondiimaterno-fetal transmission rate of 30% gave an estimate of 1·80/1000 neonates as congenitally infected. The increased mean age (28·7vs26·7 years,P < 0·001) of pregnant women was probably the most important factor in abolishing the effect of falling prevalence rates.
Collapse
|